(Q87532146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

T E Salt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

S Nizari

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

H Russ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

1 reference

9 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

published in

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

440-446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

Alzheimer's peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer's disease.

12 March 2020

cites work

1 reference

12 December 2020

Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure

1 reference

12 December 2020

The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium

1 reference

12 December 2020

The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration

1 reference

12 December 2020

Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.

1 reference

12 December 2020

Neuroprotection: is it already applicable to glaucoma therapy?

1 reference

12 December 2020

The cause of neuronal degeneration in Alzheimer's disease

1 reference

12 December 2020

Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina

1 reference

12 December 2020

Neuroprotection in glaucoma - Is there a future role?

1 reference

12 December 2020

A rat model of chronic pressure-induced optic nerve damage

1 reference

12 December 2020

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

1 reference

12 December 2020

Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases

1 reference

12 December 2020

Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy

1 reference

12 December 2020

Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures

1 reference

12 December 2020

Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

1 reference

12 December 2020

Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome

1 reference

12 December 2020

Targeting amyloid-beta in glaucoma treatment.

1 reference

12 December 2020

The molecular basis of retinal ganglion cell death in glaucoma

1 reference

12 December 2020

Neuroprotective effect of memantine in different retinal injury models in rats

1 reference

12 December 2020

Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool

1 reference

12 December 2020

High occurrence rate of glaucoma among patients with Alzheimer's disease

1 reference

12 December 2020

Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina

1 reference

12 December 2020

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

12 December 2020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

12 December 2020

Morphological and functional retinal impairment in Alzheimer's disease patients

1 reference

12 December 2020

Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL.

1 reference

12 December 2020

Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned

1 reference

12 December 2020

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo

1 reference

12 December 2020

Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures

1 reference

12 December 2020

Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision.

1 reference

12 December 2020

Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo

1 reference

12 December 2020

Glaucoma: ocular Alzheimer's disease?

1 reference

12 December 2020

Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas

1 reference

12 December 2020

10.1007/S12640-014-9488-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25106883%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference